GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Hepatitis/EUS-guided liver biopsy – a novel technique (GIE, Jan-2026)

EUS-guided liver biopsy – a novel technique (GIE, Jan-2026)

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated January 1, 2026

Quick Answer

### Indications of EUS-Guided Liver Biopsy EUS-guided liver biopsy (EUS-LB) is increasingly utilized as a minimally invasive technique for obtaining liver tissue samples. Common indications for EUS-LB include: 1.


### Indications of EUS-Guided Liver Biopsy

EUS-guided liver biopsy (EUS-LB) is increasingly utilized as a minimally invasive technique for obtaining liver tissue samples. Common indications for EUS-LB include:

1. Evaluation of unexplained liver abnormalities, such as elevated liver enzymes or abnormal imaging findings.

2. Diagnosis and staging of liver diseases, including nonalcoholic fatty liver disease (NAFLD), autoimmune hepatitis, and cirrhosis.

3. Assessment of focal liver lesions to distinguish benign from malignant pathology.

4. Sampling in patients with challenging anatomies or high risk for adverse events associated with percutaneous or transjugular liver biopsy.

### Difference Between 22-Gauge and 19-Gauge Needles

The gauge of the needle used during EUS-LB significantly impacts specimen quality and procedural outcomes:

1. **19-Gauge Needle**:

  • Traditionally preferred for EUS-LB due to its ability to obtain larger tissue samples with higher adequacy rates.
  • Provides specimens with longer aggregate length and higher counts of complete portal tracts (CPTs), which are critical for accurate pathological evaluation.
  • Associated with higher rates of blood contamination and may pose a greater risk of adverse events, particularly in patients with challenging anatomies.

2. **22-Gauge Needle**:

  • Historically considered inferior due to smaller sample sizes and lower adequacy rates compared to 19-gauge needles.
  • Emerging evidence suggests that the use of novel techniques, such as hydrostatic sampling, can improve performance and tissue adequacy, making 22-gauge needles a viable option.
  • Offers advantages in patients with high-risk profiles or difficult anatomical considerations due to its smaller size and reduced invasiveness.

### Hydrostatic Sampling Technique (HST)

The hydrostatic sampling technique (HST) is a novel method that enhances the quality of tissue samples obtained during EUS-LB. Key features include:

1. Improved tissue adequacy: In the study provided, the HST achieved high adequacy rates (≥93%) for both 22-gauge and 19-gauge needles, meeting clinical standards.

2. Reduced blood contamination: The 22-gauge HST demonstrated significantly less blood contamination compared to both 19-gauge HST and wet suction (WS).

3. Comparable performance to traditional techniques: The HST allows 22-gauge needles to achieve similar specimen adequacy as 19-gauge needles, making it a promising option for patients at high risk for procedural complications.

### Conclusion

The findings in the study suggest that the hydrostatic sampling technique is a significant advancement in EUS-guided liver biopsy. Specifically:

1. The HST enables the use of 22-gauge needles with tissue adequacy rates comparable to 19-gauge needles, while reducing blood contamination.

2. This technique may be particularly beneficial for patients with challenging anatomies or high risk of adverse events, providing a safer and equally effective alternative to traditional biopsy approaches.

3. The adoption of HST could expand the indications and applicability of EUS-LB, making it a more versatile and patient-centered diagnostic tool.

Related Q&A

A Steroid-Sparing Breakthrough(Obexelimab) for IgG4-Related Disease: NEJM | June 2026

Introduction: IgG4-related disease (IgG4-RD) is a chronic fibroinflammatory disorder that can affect virtually any organ. Although glucocorticoids remain the mainstay of treatment, relapse is common after tapering, and long-term steroid toxicity remains a major concern....

HBV Reactivation During Immunosuppressive Therapy: Alimentary Pharmacology & Therapeutics | July 2026

Introduction: Hepatitis B virus (HBV) reactivation remains a potentially serious complication of immunosuppressive and anticancer therapies. While current guidelines classify patients into high-, moderate-, and low-risk categories, this editorial discusses new real-world evidence suggesting that...

Advancing Liver Health in a Shifting Global Landscape: Nat Re Gastro & Hepatol | July 2026

Introduction: Liver disease is entering a new era. While steatotic liver disease (SLD) is rapidly becoming one of the world's leading non-communicable diseases, progress toward viral hepatitis elimination has slowed. This editorial highlights the urgent...

ML Predicts Response to TPE in Pediatric ALF: JCEH | July 2026

Introduction: Therapeutic plasma exchange (TPE) is increasingly used in pediatric acute liver failure (ALF), but it artificially lowers bilirubin and INR, making it difficult to determine whether a child is truly improving or requires urgent...

Alcohol Intake and Health Study: J of Studies on Alcohol and Drugs | July 2026

Introduction: For decades, low-to-moderate alcohol consumption has been considered by some to offer potential cardiovascular benefits. This comprehensive U.S. modeling study re-evaluated the lifetime health impact of alcohol consumption using contemporary cause-specific data on alcohol-related...

Genetic Testing in Adult Cholestatic Liver Disease: Gut | June 2026

Introduction: Advances in genetic sequencing have transformed the understanding of cholestatic liver diseases. Conditions once considered exclusive to children are now recognized in adolescents and adults, with genetic variants increasingly explaining unexplained cholestasis, recurrent pruritus,...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer